Exelixis Market Cap

Exelixis has a market cap or net worth of $13.32 billion as of June 9, 2026. Its market cap has increased by 15.22% in one year.

Market Cap

13.32B

Enterprise Value

12.06B

1-Year Change

15.22%

Ranking

#788

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $13.32B, an increase of 2,011.49%. That is a compound annual growth rate of 12.36%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2026	13.32B	13.34%
Dec 31, 2025	11.75B	23.57%
Dec 31, 2024	9.51B	27.47%
Dec 29, 2023	7.46B	44.19%
Dec 30, 2022	5.17B	-10.54%
Dec 31, 2021	5.78B	-7.11%
Dec 31, 2020	6.23B	16.30%
Dec 31, 2019	5.35B	-8.96%
Dec 31, 2018	5.88B	-34.61%
Dec 29, 2017	8.99B	110.58%
Dec 30, 2016	4.27B	233.29%
Dec 31, 2015	1.28B	355.89%
Dec 31, 2014	281.10M	-75.11%
Dec 31, 2013	1.13B	34.59%
Dec 31, 2012	839.00M	36.62%
Dec 30, 2011	614.10M	-31.37%
Dec 31, 2010	894.80M	13.07%
Dec 31, 2009	791.40M	49.29%
Dec 31, 2008	530.10M	-41.23%
Dec 31, 2007	902.00M	4.64%
Dec 29, 2006	862.00M	10.08%
Dec 30, 2005	783.10M	10.19%
Dec 31, 2004	710.70M	41.83%
Dec 31, 2003	501.10M	9.05%
Dec 31, 2002	459.50M	-44.16%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genmab	15.27B
Jazz Pharmaceuticals	14.56B
BridgeBio Pharma	13.20B
Ascendis Pharma	12.78B
Ionis Pharmaceuticals	12.15B
Axsome Therapeutics	12.10B
Summit Therapeutics	10.95B
BioMarin Pharmaceutical	10.93B

Market Cap Rankings